AR008386A1 - DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE. - Google Patents

DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE.

Info

Publication number
AR008386A1
AR008386A1 ARP970102441A ARP970102441A AR008386A1 AR 008386 A1 AR008386 A1 AR 008386A1 AR P970102441 A ARP970102441 A AR P970102441A AR P970102441 A ARP970102441 A AR P970102441A AR 008386 A1 AR008386 A1 AR 008386A1
Authority
AR
Argentina
Prior art keywords
antihistamine
pharmaceutical composition
composition containing
benzimidazole derivatives
activity
Prior art date
Application number
ARP970102441A
Other languages
English (en)
Spanish (es)
Original Assignee
Faes Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Farma Sa filed Critical Faes Farma Sa
Publication of AR008386A1 publication Critical patent/AR008386A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP970102441A 1996-06-04 1997-06-05 DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE. AR008386A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09601236A ES2124167B1 (es) 1996-06-04 1996-06-04 Nuevos derivados del bencimidazol con actividad antihistaminica.

Publications (1)

Publication Number Publication Date
AR008386A1 true AR008386A1 (es) 2000-01-19

Family

ID=8295035

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970102441A AR008386A1 (es) 1996-06-04 1997-06-05 DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE.

Country Status (27)

Country Link
US (1) US5877187A (enrdf_load_stackoverflow)
EP (1) EP0818454B1 (enrdf_load_stackoverflow)
JP (1) JP4218991B2 (enrdf_load_stackoverflow)
CN (1) CN1105716C (enrdf_load_stackoverflow)
AR (1) AR008386A1 (enrdf_load_stackoverflow)
AT (1) ATE264317T1 (enrdf_load_stackoverflow)
AU (1) AU725700B2 (enrdf_load_stackoverflow)
BR (1) BR9703276A (enrdf_load_stackoverflow)
CA (1) CA2206754C (enrdf_load_stackoverflow)
CZ (1) CZ289278B6 (enrdf_load_stackoverflow)
DE (2) DE69728608T2 (enrdf_load_stackoverflow)
DK (1) DK0818454T3 (enrdf_load_stackoverflow)
ES (1) ES2124167B1 (enrdf_load_stackoverflow)
FR (1) FR11C0023I2 (enrdf_load_stackoverflow)
HR (1) HRP970307B1 (enrdf_load_stackoverflow)
HU (1) HU227598B1 (enrdf_load_stackoverflow)
IN (1) IN186319B (enrdf_load_stackoverflow)
LU (1) LU91798I2 (enrdf_load_stackoverflow)
MX (1) MXPA97004127A (enrdf_load_stackoverflow)
NO (2) NO313195B1 (enrdf_load_stackoverflow)
PL (1) PL188908B1 (enrdf_load_stackoverflow)
PT (1) PT818454E (enrdf_load_stackoverflow)
RU (1) RU2182150C2 (enrdf_load_stackoverflow)
SI (1) SI0818454T1 (enrdf_load_stackoverflow)
TR (1) TR199700464A2 (enrdf_load_stackoverflow)
TW (1) TW438794B (enrdf_load_stackoverflow)
ZA (1) ZA974893B (enrdf_load_stackoverflow)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4394799A (en) 1998-07-01 2000-01-24 Takeda Chemical Industries Ltd. Retinoid-associated receptor regulators
HRP20010484B1 (hr) 1998-11-27 2010-08-31 Basf Aktiengesellschaft Supstituirani benzimidazoli, njihovo pripravljanje i korištenje
ES2151442B1 (es) * 1999-01-11 2001-07-01 Espanola Prod Quimicos Nuevo derivado del bencenoetanol.
US6826561B2 (en) 2000-05-22 2004-11-30 Broadcom Corporation Method and apparatus for performing a binary search on an expanded tree
AU2002255017B2 (en) * 2002-04-19 2008-11-13 Faes Farma, S.A. Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic acid
RU2288917C2 (ru) * 2002-04-19 2006-12-10 Фаэс Фарма, С.А. Полиморф 4-[2-[4-[1-(2-этоксиэтил)-1h-бензимидазол-2-ил]-1-пиперидинил]этил]-альфа, альфа-диметилбензолуксусной кислоты, способ его получения, фармацевтический препарат на его основе и его применение
ES2277088T3 (es) * 2002-06-13 2007-07-01 Vertex Pharmaceuticals Incorporated Derivados del acido 2-ureido-6-heteroaril-3h-benzoimidazol-4-carboxilico y compuestos relacionados como inhibidores de girasa y/o topoisomerasa iv para el tratamiento de infecciones bacterianas.
US20070188330A1 (en) * 2006-01-24 2007-08-16 Morhard Robert C System and method for detecting, monitoring, tracking and identifying explosive materials using ID marks
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
CN101952273B (zh) * 2008-02-12 2014-11-12 柳韩洋行 2-甲基2’-苯基丙酸衍生物的制备方法和中间体化合物
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
CN102675101B (zh) * 2012-05-16 2014-01-29 王蕾 2-(4-卤乙基)苯基-2-甲基丙酸酯的制备方法及合成比拉斯汀的方法
CZ307500B6 (cs) 2012-08-15 2018-10-24 Zentiva, K.S. Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty
MX366869B (es) * 2013-03-15 2019-07-29 Hercules Inc Composición y método para producir composiciones para el cuidado personal con propiedades de deposición mejoradas.
CN103214455B (zh) * 2013-03-30 2018-08-31 北京万全德众医药生物技术有限公司 一种比拉斯汀的制备方法
CN103214454A (zh) * 2013-03-30 2013-07-24 北京万全德众医药生物技术有限公司 一种比拉斯汀晶型及制备方法
WO2014188453A2 (en) * 2013-05-24 2014-11-27 Msn Laboratories Private Limited Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid
CN103351380B (zh) * 2013-06-30 2019-01-22 北京万全德众医药生物技术有限公司 一种制备比拉斯汀的方法
CN104447683A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的比拉斯汀化合物
CN103896915A (zh) * 2014-04-01 2014-07-02 中国药科大学 苯并咪唑类衍生物、其制备方法及其在医药上的应用
EP3040334A1 (en) 2014-12-29 2016-07-06 Faes Farma, S.A. New benzimidazole derivatives as antihistamine agents
CN106349214B (zh) * 2015-07-13 2020-11-03 南京长澳医药科技有限公司 一种比拉斯汀杂质的制备方法
WO2017017301A1 (es) * 2015-07-24 2017-02-02 Urquima, S.A Formas cristalinas de bilastina y procedimientos para su preparación
CN105272977A (zh) * 2015-09-19 2016-01-27 万全万特制药江苏有限公司 一种制备比拉斯汀中间体的方法
EP3170817A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Co-crystals of benzimidazole compounds
EP3170816A1 (en) 2015-11-20 2017-05-24 Faes Farma, S.A. Supersaturated compositions of benzimidazole compounds
WO2017167949A1 (en) 2016-04-01 2017-10-05 Krka, D.D., Novo Mesto Crystalline forms of bilastine
EP3452462A4 (en) * 2016-05-05 2019-10-23 MSN Laboratories Private Limited, R&D Center SOLID STATE FORMS OF 2- [4- (2- {4- [1- (2-ETHOXYETHYL) -1H-BENZIMIDAZOL-2-YL] -1-PIPERIDINYL} ETHYL) PHENYL] -2-METHYLPROPANOIC ACID AND PREPARATION METHOD THEREOF
CN107365298A (zh) * 2017-03-14 2017-11-21 罗欣生物科技（上海）有限公司 一种2‑甲基‑2’‑苯基丙酸衍生物的制备方法
CN109456316A (zh) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 一种比拉斯汀杂质的制备方法
EP3453384B1 (en) 2017-09-07 2020-05-27 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical tablet composition comprising bilastine
MX2020003834A (es) 2017-10-16 2020-08-06 Faes Farma Sa Composiciones acuosas que comprenden bilastina y mometasona.
EP3641735B1 (en) 2017-12-18 2021-02-24 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical tablet composition comprising bilastine form 3 and a water-soluble filler
ES2835287T3 (es) 2017-12-18 2021-06-22 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica de comprimido que comprende la forma polimórfica 3 de bilastina y aluminometasilicato de magnesio
MA51612B1 (fr) 2018-01-18 2021-06-30 Faes Farma Sa Compositions ophtalmiques comprenant de la bilastine, une bêta-cyclodextrine et au moins un agent gélifiant
CN109081827A (zh) * 2018-11-06 2018-12-25 北京天弘天达医药科技股份有限公司 一种比拉斯汀的制备方法及应用
EP3725298A1 (en) 2019-04-16 2020-10-21 Faes Farma, S.A. Stable and preserved pharmaceutical compositions of bilastine
PE20231844A1 (es) 2020-07-30 2023-11-21 Faes Farma Sa Sistema de liberacion de farmacos descongestivos y bilastina
CN112110893A (zh) * 2020-10-28 2020-12-22 山东齐环医药科技有限公司 一种比拉斯汀的制备方法
US20230414597A1 (en) 2020-11-18 2023-12-28 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound
EP4267109A1 (en) 2020-12-23 2023-11-01 Noucor Health S.A. A non-micronized bilastine composition
MX2024009978A (es) 2022-02-17 2024-08-26 Faes Farma Sa Composicion de bilastina para administracion parenteral una vez al dia.
WO2024224326A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine
WO2024224308A1 (en) * 2023-04-27 2024-10-31 Leiutis Pharmaceuticals Llp Liquid parenteral formulations of bilastine free of cyclodextrins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
AU7759591A (en) * 1990-04-13 1991-11-11 Smithkline Beecham Corporation Substituted benzimidazoles
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
EP1214937B1 (en) * 1992-08-03 2007-05-30 Sepracor Inc. Terfenadine carboxylate and the treatment of dermal irritation
NZ267830A (en) * 1993-06-25 1998-05-27 Merrell Pharma Inc Preparation of 4-diphenylmethyl or 4-diphenylmethoxy piperidine derivatives and intermediates therefor

Also Published As

Publication number Publication date
DE122011000006I1 (de) 2011-06-16
SI0818454T1 (en) 2004-08-31
AU2467297A (en) 1997-12-11
PL188908B1 (pl) 2005-05-31
HUP9700997A1 (hu) 1999-09-28
ATE264317T1 (de) 2004-04-15
IN186319B (enrdf_load_stackoverflow) 2001-08-04
JPH1059961A (ja) 1998-03-03
PT818454E (pt) 2004-08-31
NO2011008I1 (no) 2011-06-06
AU725700B2 (en) 2000-10-19
NO313195B1 (no) 2002-08-26
CN1105716C (zh) 2003-04-16
TW438794B (en) 2001-06-07
CN1176964A (zh) 1998-03-25
CZ172397A3 (en) 1997-12-17
FR11C0023I1 (enrdf_load_stackoverflow) 2011-08-19
CA2206754A1 (en) 1997-12-04
ES2124167A1 (es) 1999-01-16
HU227598B1 (en) 2011-09-28
NO972525L (no) 1997-12-05
NO972525D0 (no) 1997-06-03
PL320358A1 (en) 1997-12-08
LU91798I2 (fr) 2011-05-23
RU2182150C2 (ru) 2002-05-10
BR9703276A (pt) 2004-08-17
ES2124167B1 (es) 1999-09-16
HRP970307B1 (en) 2002-02-28
HRP970307A2 (en) 1998-04-30
CZ289278B6 (cs) 2001-12-12
DE69728608T2 (de) 2005-04-21
US5877187A (en) 1999-03-02
DK0818454T3 (da) 2004-07-12
FR11C0023I2 (fr) 2012-03-16
EP0818454B1 (en) 2004-04-14
HU9700997D0 (en) 1997-07-28
NO2011008I2 (no) 2012-05-14
DE69728608D1 (de) 2004-05-19
TR199700464A3 (tr) 1997-12-21
ZA974893B (en) 1997-12-30
TR199700464A2 (xx) 1997-12-21
CA2206754C (en) 2007-01-23
JP4218991B2 (ja) 2009-02-04
MXPA97004127A (es) 2005-07-25
EP0818454A1 (en) 1998-01-14

Similar Documents

Publication Publication Date Title
AR008386A1 (es) DERIVADOS DE BENZIMIDAZOL CON ACTIVIDAD ANTIHISTAMINICA Y COMPOSICIoN FARMACÉUTICA ANTIHISTAMINICA QUE LOS CONTIENE.
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
IT1264451B1 (it) 3-(carbossimetossifenil)-benzofuran-2-oni come agenti stabilizzanti
AR001332A1 (es) Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen.
PE20010286A1 (es) Derivados de indoloxoacetil piperazina como agentes antivirales
GT200000005A (es) Derivados biciclicos sustituidos utiles como agentes contra el cancer.
ES2188584T3 (es) Derivados heterociclicos de amina.
ATE327977T1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
ES2230719T3 (es) Compuestos basados en azabencimidazol para modular una funcion de proteina-quinasa de serina/treonina.
ECSP066967A (es) Derivados de tetrahidroquinolina y un procedimiento para preparar los mismos
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
PA8480101A1 (es) Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos
IL56369A (en) Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
ES2196806T3 (es) Derivados de fenilurea y de feniltiourea.
AR029634A1 (es) Compuestos derivados heterociclicos utiles como agentes anticancerosos, composicion farmaceutica y procedimiento de tratamiento
ES2095976T3 (es) Compuestos de pirazolopiridina y procedimiento para su preparacion.
ES2169248T3 (es) Compuestos aromaticos y composiciones farmaceuticas que los contienen.
ATE25682T1 (de) Indol-3-carboxamid-derivate.
AR007021A1 (es) Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
UY26070A1 (es) Derivados de resorcinol
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
ES2153019T3 (es) Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR025351A1 (es) Agonistas retinoides selectivos par
AR027578A1 (es) Derivados de indano

Legal Events

Date Code Title Description
FG Grant, registration